U.S. flag

An official website of the United States government

NM_000061.3(BTK):c.1805C>T (p.Thr602Ile) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 16, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000432214.1

Allele description [Variation Report for NM_000061.3(BTK):c.1805C>T (p.Thr602Ile)]

NM_000061.3(BTK):c.1805C>T (p.Thr602Ile)

Gene:
BTK:Bruton tyrosine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq22.1
Genomic location:
Preferred name:
NM_000061.3(BTK):c.1805C>T (p.Thr602Ile)
HGVS:
  • NC_000023.11:g.101353297G>A
  • NG_009616.1:g.37928C>T
  • NG_011734.1:g.673C>T
  • NM_000061.3:c.1805C>TMANE SELECT
  • NM_001287344.2:c.1907C>T
  • NM_001287345.2:c.1277C>T
  • NP_000052.1:p.Thr602Ile
  • NP_000052.1:p.Thr602Ile
  • NP_001274273.1:p.Thr636Ile
  • NP_001274274.1:p.Thr426Ile
  • LRG_128t1:c.1805C>T
  • LRG_128:g.37928C>T
  • LRG_128p1:p.Thr602Ile
  • NC_000023.10:g.100608285G>A
  • NM_000061.2:c.1805C>T
Protein change:
T426I
Links:
dbSNP: rs1057521116
NCBI 1000 Genomes Browser:
rs1057521116
Molecular consequence:
  • NM_000061.3:c.1805C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001287344.2:c.1907C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001287345.2:c.1277C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000521116GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely pathogenic
(Feb 16, 2016)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000521116.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The T602I variant in the BTK gene has been reported previously in a male with X-linked agammaglobulinemia (Chun et al., 2008). The T602I variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The T602I variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is not conserved. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Missense variants in nearby residues (P597T, Y598D, Y598S, Y598C, E605G, T606P, A607D) have been reported in the Human Gene Mutation Database in association with agammaglobulinemia (Stenson et al., 2014), supporting the functional importance of this region of the protein. The T602I variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022